|
2024 Conference Publication Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national studyDuplancic, Christine, Wainwright, Claire, Thomson, Rachel, Rogers, Geraint, Clements, Archie, Floto, Andre and Bell, Scott (2024). Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trialRice, Megan, Hicks, Daniel, Jong, Tiffany, Gailer, Nicolas, Joshi, Sri, Stevens, Luke, Lee, Kate, Thomson, Rachel, Burke, Andrew, Grimwood, Keith, Bell, Scott, Clark, Julia and Wainwright, Claire E. (2024). Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3 |
|
2024 Conference Publication Mycobacteria acquisition from potable waterRamsay, K., Smith, K., Carter, R., Clayton, M., Thomson, R. and Bell, S. (2024). Mycobacteria acquisition from potable water. TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science,, Gold Coast, QLD, Australia, 22-26 March 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14673 |
|
2023 Conference Publication In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolatesBurke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968 |
|
2019 Conference Publication High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in AustraliaDuplancic, C., Thomson, R., Wainwright, C. and Bell, S. C. (2019). High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia. 33rd Annual North American Cystic Fibrosis Conference, Nashville, TN United States, 31 October – 2 November 2019. Hoboken, NJ United States: John Wiley & Sons. |
|
2019 Conference Publication Mycobacterium abscessus point source outbreak in the local potable water supply affecting people with cystic fibrosisStockwell, R. E., Thomson, R., Leong, L. E., Wheeler, N. E., Bryant, J., Wood, M. E., Sherrard, L. J., Carter, R., Tolson, C., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2019). Mycobacterium abscessus point source outbreak in the local potable water supply affecting people with cystic fibrosis. Annual North American Cystic Fibrosis Conference, Nashville, TN, United States, 31 October - 2 November 2019. Hoboken, NJ, United States: John Wiley & Sons. |
|
2018 Conference Publication PREVALENCE OF SHARED <i>MYCOBACTERIUM ABSCESSUS</i> COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATIONStockwell, R. E., Leong, L., Wheeler, N., Bryant, J., Wood, M. E., Sherrard, L., Thomson, R., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2018). PREVALENCE OF SHARED MYCOBACTERIUM ABSCESSUS COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION. HOBOKEN: WILEY. |
|
2018 Conference Publication Infection control in Australian and New Zealand cystic fibrosis centresStockwell, R., Wood, M., Moore, V and Bell, S. (2018). Infection control in Australian and New Zealand cystic fibrosis centres. ANZSRS/TSANZ Annual Scientific Meeting, Adelaide, Australia, 23-27 March 2018. Richmond, VIC, Australia: Wiley-Blackwell. |
|
2016 Conference Publication Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosisSherrard, L., Tai, A., Wee, B., Ramsay, K., Kidd, T., Ben Zakour, N., Whiley, D., Beatson, S. and Bell, S. C. (2016). Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis. Annual North American Cystic Fibrosis Conference, Orlando, FL, United States, 27-29 October 2016. Hoboken, NJ, United States: John Wiley & Sons. |
|
2014 Conference Publication The Effect of Ivacaftor in Individuals with Cystic Fibrosis and Severe Lung Disease: Analysis of Data From the Australian Named Patient ProgrammeWainwright, C., Bell, S., Morton, J., Ryan, G., Serisier, D., Bye, P., Mulrennan, S., Daley, C. and Greville, H. (2014). The Effect of Ivacaftor in Individuals with Cystic Fibrosis and Severe Lung Disease: Analysis of Data From the Australian Named Patient Programme. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10 |
|
2014 Conference Publication Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf)Tai, A., Kidd, T., Ramsay, K., Bell, S. and Whiley, D. (2014). Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf). Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10 |
|
2014 Conference Publication Spreading the Word: Introducing Pre-Service Teachers to Programming in the K-12 ClassroomBell, Scott, Frey, Tim and Vasserman, Eugene (2014). Spreading the Word: Introducing Pre-Service Teachers to Programming in the K-12 Classroom. 45th ACM SIGCSE Technical Symposium on Computer Science Education (SIGCSE), Atlanta Ga, Mar 05-08, 2014. NEW YORK: ASSOC COMPUTING MACHINERY. doi: 10.1145/2538862.2538963 |
|
2013 Conference Publication The Social Network in Cystic Fibrosis (Cf) Centre Care and the Risk of Shared Pseudomonas Aeruginosa (Pa) Strain InfectionKidd, T. J., Magalhaes, R. J. Soares, Paynter, S. and Bell, S. C. (2013). The Social Network in Cystic Fibrosis (Cf) Centre Care and the Risk of Shared Pseudomonas Aeruginosa (Pa) Strain Infection. HOBOKEN: WILEY-BLACKWELL. |
|
2013 Conference Publication Perturbation of Sputum Microbiota by Intravenous Antibiotics in Cystic Fibrosis Is Short-LivedSmith, D. J., Badrick, A. C., Krause, L., Bell, S. C., Anderson, G. J. and Reid, D. W. (2013). Perturbation of Sputum Microbiota by Intravenous Antibiotics in Cystic Fibrosis Is Short-Lived. 2013 Annual Scientific Meetings of The Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, Darwin, NT Australia, 22 - 27 March 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12046 |
|
2013 Conference Publication Viability of pseudomonas aeruginosa (Pa) in cough aerosols from adult cystic fibrosis (CF) patientsKidd, T. J., Knibbs, L. D., Johnson, G., Kattenbelt, J. A., Ramsay, K. A., Wood, M., Beevers, A., O'Rourke, P. K., Wainwright, C. E., Grimwood, K., Sly, P., Morawska, L. and Bell, S. C. (2013). Viability of pseudomonas aeruginosa (Pa) in cough aerosols from adult cystic fibrosis (CF) patients. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT Australia, 22-27 March 2013. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/resp.12045 |
|
2013 Conference Publication Methicillin-Resistant Staphyloccus Aureus (Mrsa) Infection in Health Care Workers with Cystic Fibrosis (Hcwcf)Wood, M. E., Ramsay, K. A., Kidd, T. J. and Bell, S. C. (2013). Methicillin-Resistant Staphyloccus Aureus (Mrsa) Infection in Health Care Workers with Cystic Fibrosis (Hcwcf). 2013 Annual Scientific Meetings of The Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, Darwin, NT Australia, 22 - 27 March 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12045 |
|
2013 Conference Publication Molecular Surveillance and Prevalence of Acquired Carbapenem Resistance in Pseudomonas Aeruginosa (Pa) Amongst Australian Cystic Fibrosis (Cf) PatientsTai, A., Kidd, T. J., Whiley, D. M., Sidjabat, H. E. and Bell, S. C. (2013). Molecular Surveillance and Prevalence of Acquired Carbapenem Resistance in Pseudomonas Aeruginosa (Pa) Amongst Australian Cystic Fibrosis (Cf) Patients. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin Convention Centre, Darwin, NT, 22-27 March 2013. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12046 |
|
2013 Conference Publication Observational Study of the Clinical Effects of Ivacaftor in Patients with Severe Cystic Fibrosis (Cf) Lung DiseaseWood, M. E., Smith, D. J., Reid, D. W. E. C. and Bell, S. C. (2013). Observational Study of the Clinical Effects of Ivacaftor in Patients with Severe Cystic Fibrosis (Cf) Lung Disease. 2013 Annual Scientific Meetings of The Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, Darwin, NT Australia, 22 - 27 March 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12046 |
|
2012 Conference Publication Pseudomonas aeruginosa resistance: Comparison between Australian cystic fibrosis (cf) centresSmith, D., Kidd, T. J., Ramsay, K. A., Wainwright, C. E., Grimwood, K. and Bell, S. C. (2012). Pseudomonas aeruginosa resistance: Comparison between Australian cystic fibrosis (cf) centres. Abstracts of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2012 Annual Scientific Meetings, 30 March–4 April 2012, Canberra, ACT, Australia. Richmond, VIC, Australia: John Wiley and Sons. |
